NMC.L Regulatory News (NMC)

London, 20 May 2015: NMC Health plc (LSE:NMC) ('NMC'), the leading integrated private healthcare provider operating across the United Arab Emirates, and one of the top global providers of fertility treatment through its Spanish subsidiary Clinica Eugin, announces that it received notification on 19 May 2015 from Mr Mark Tompkins, Chairman of the Company, that on 19 May 2015, he and his wife, Mrs Sarah Tompkins, undertook a number of share transactions as follows:

(*) Note: The purchase of shares by both Mr Tompkins and Mrs Tompkins was made through their respective ISA accounts.

As a result of these transactions, Mr Tompkins' interest in the shares of the Company remains unchanged at 17,083 shares, representing 0.01% of the current issued share capital of the Company, including Mrs Sarah Tompkins' direct interest in the shares of the Company of 7,983 shares, representing 0.004% of the current issued share capital of the Company.

Contacts

Investors

NMC

Simon Watkins, Group Company Secretary +44 (0)20 3102 9460

Media:

FTI Consulting, London

Matthew Cole +44 (0)20 3727 1101

FTI Consulting, Gulf

Shane Dolan +971 (0)4 437 2100

About NMC

NMC Health plc group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Healthcare Division currently operates or manages seven hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. The enlarged company received almost 2.8m patients in 2014.The group also operates a significant UAE wide Distribution business supplying product lines across several key market segments, including: Pharmaceutical, FMCG, Food and Scientific and Medical Equipment. NMC Health plc group reported revenues of US$ 644m in 2014.

In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. At the time of its IPO, the group raised funds to enable it to pursue a further growth plan with a number of capital projects for new healthcare facilities in Abu Dhabi and Dubai. NMC Health plc is a constituent of the FTSE 250 Index.